Table 3.
Outcomes of the Procedures
| EUS-GBD (n=10) | PTGBD (n=11) | PTGBA (n=27) | |
|---|---|---|---|
| Technical success (n) | 90% (9) | 100% (11) | 100% (27) |
| Clinical effectiveness (n) | 89% (8) | 91% (10) | 63% (17) |
| Adverse events (n) | 40% (4)a) | 9% (1)b) | 0 (0) |
| Recurrence rate (n) | 38% (3) | 10% (1) | 18% (3) |
| Stent patency period, mean, days (95% CI) | 252 (128–375) | N/A | N/A |
| Overall survival, median, days (95% CI) | 259 (68–390) | 178 (10–302) | 188 (1–469) |
CI, confidence interval; EUS-GBD, endoscopic ultrasonography-guided gallbladder drainage; N/A, not available; PTGBA, percutaneous transhepatic gallbladder aspiration; PTGBD, percutaneous transhepatic gallbladder drainage.
a)
Mild bile peritonitis,
b)
Transthoracic drainage.